Hi, what are you looking for?
A family earning $75,000 can afford 23% of homes for sale. Five years ago, they could afford 50% of listings.
How did remote work, a perk for office workers, turn into such a PR disaster?
You're probably brushing your teeth wrong, this dentist says — which has tongues wagging
The curious case of a regional bank's insider stock sales
55% of women don’t know if they have enough money saved. Here’s what you can do now.
Crypto.com Pauses US Institutional Trading Service Following Regulatory Pressure | Bitcoinist.com
Crypto Queen Adviser, Under House Arrest, Goes Missing Before Facing US Justice
Ethereum Success Hinges On Vitalik Buterin's Proposed '3 Transitions' – What Are They?
Bitcoin Price Set To 'Sprint' Toward $40,000, This Prominent Trader Claims
Crypto.com Shuts Down US Institutional Exchange, Here's Why | Bitcoinist.com
Can AI make older adults feel less lonely?
Secure your startup’s future by watching the big corporations
Deal Dive: Finally, a startup building a network for those who could benefit the most
This week in foodtech: Cultivated meat is still a sizzling topic
Sol Reader is a VR headset exclusively for reading books
3 Advantages of Using Pooled PBMCs to Detect and Quantify Pyrogens | Cytologics
Monocytes: A Critical Link between Periodontal Disease and Cardiovascular Disease | Cytologics
PBMC Pellets: Essential Tool for Immunology Research | Cytologics
Natural Killer Cells: Cell Biology and Research Applications | Cytologics
Low Resolution vs. High Resolution HLA Typing: What Do You Really Need for Your Experiment? | Cytologics
Golden Minerals tables initial resource for Yoquivo silver-gold project in Mexico
Iron ore price falls on China warning, production controls in Tangshan
Evolution Mining stock jumps as underground production starts at Cowal
How silicon, gold, copper help destroy covid-19 virus
Peru expects 74 mining projects to become operative in 2023
The Food and Drug Administration said Tuesday that it approved Innoviva’s INVA, -0.73% Xacduro pneumonia treatment, which fights the Acinetobacter bacteria. The federal regulator said Xacduro, which treats ventilator-associated bacterial pneumonia and hospital-acquired bacterial pneumonia, is hard to treat and poses a great threat to human health. The FDA granted approval of Xacduro, administered by
The Food and Drug Administration said Tuesday that it approved Innoviva’s INVA,
The federal regulator said Xacduro, which treats ventilator-associated bacterial pneumonia and hospital-acquired bacterial pneumonia, is hard to treat and poses a great threat to human health.
The FDA granted approval of Xacduro, administered by intravenous infusion, to Entasis Therapeutics, acquired by the pharma company Innoviva last year.
NAL spodumene concentrate production remains targeted for H1 2023 with revenue potential in Q3 2023. Credit: Piedmont Piedmont Lithium (Nasdaq: PLL; ASX: PLL) announced...
SAN FRANCISCO (MarketWatch) — Among the companies whose shares are expected to see active trade in Thursday’s session are BlackBerry Ltd., Oracle Corp., and...
Over 90% of cybercrime activities that lead to financial fraud or identity theft start with an email impersonation, commonly known as phishing and spoofing....
Following a down year for the stock market, there is no shortage of recession predictions for 2023, especially as the Federal Reserve has signaled...
